Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation
Fused in sarcoma (FUS) is a predominantly nuclear multifunctional RNA/DNA‐binding protein that regulates multiple aspects of gene expression. FUS mutations are associated with familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobe degeneration (FTLD) in humans. At the molecular level,...
Gespeichert in:
Veröffentlicht in: | Glia 2020-10, Vol.68 (10), p.2040-2056 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2056 |
---|---|
container_issue | 10 |
container_start_page | 2040 |
container_title | Glia |
container_volume | 68 |
creator | Guzman, Kelly M. Brink, Lauren E. Rodriguez‐Bey, Guillermo Bodnar, Richard J. Kuang, Lisha Xing, Bin Sullivan, Mara Park, Hyun J. Koppes, Erik Zhu, Haining Padiath, Quasar Cambi, Franca |
description | Fused in sarcoma (FUS) is a predominantly nuclear multifunctional RNA/DNA‐binding protein that regulates multiple aspects of gene expression. FUS mutations are associated with familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobe degeneration (FTLD) in humans. At the molecular level, the mutated FUS protein is reduced in the nucleus but accumulates in cytoplasmic granules. Oligodendrocytes (OL) carrying clinically relevant FUS mutations contribute to non‐cell autonomous motor neuron disease progression, consistent with an extrinsic mechanism of disease mediated by OL. Knocking out FUS globally or in neurons lead to behavioral abnormalities that are similar to those present in FTLD. In this study, we sought to investigate whether an extrinsic mechanism mediated by loss of FUS function in OL contributes to the behavioral phenotype. We have generated a novel conditional knockout (cKO) in which Fus is selectively depleted in OL (FusOL cKO). The FusOL cKO mice show increased novelty‐induced motor activity and enhanced exploratory behavior, which are reminiscent of some manifestations of FTLD. The phenotypes are associated with greater myelin thickness, higher number of myelinated small diameter axons without an increase in the number of mature OL. The expression of the rate‐limiting enzyme of cholesterol biosynthesis (HMGCR) is increased in white matter tracts of the FusOLcKO and results in higher cholesterol content. In addition, phosphorylation of Akt, an important regulator of myelination is increased in the FusOLcKO. Collectively, this work has uncovered a novel role of oligodendrocytic Fus in regulating myelin deposition through activation of Akt and cholesterol biosynthesis.
Myelin thickness and myelinated small axons are increased in FusOLcKO mice.
Activation of HMGCR expression leads to higher cholesterol in FusOLcKO mice.
Akt is activated in FusOLcKO mice.
FusOLcKO mice exhibit enhanced exploration and motor activity |
doi_str_mv | 10.1002/glia.23825 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7772959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2379020941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4485-85edc37bf8e06e88739838085944a159bc305d0369682509219991e9d819c043</originalsourceid><addsrcrecordid>eNp9kcFuGyEQQFHVqnHSXvoBFVIvVaRNYGG9cKlkWU0ayVIuuSMMY5uUXVxgE-2_9GPL2mnU5NATg-bNY5hB6BMlF5SQ-nLrnb6omaibN2hGiRQVpWz-Fs2IkLyiXNITdJrSPSG0XNr36ITVVLSc0Bn6vQy9ddmFXntsYe9hinHY4KshYVci77bBQm9jMGOGhD1om3AOuAs5RLwb9xC1ye7B5RHr3pYiE0EnsLgbwRdF0YZ0eAPrlIJxOpfko8s7vPiZDzVmFzykDDF4fJDpCf-A3m20T_Dx6TxDd1ff75Y_qtXt9c1ysaoM56KpRAPWsHa9EUDmIETLpGCCiEZyrmkj14aRxhI2l_MyIyJrKqWkIK2g0hDOztC3o3Y_rLuigj5H7dU-uk7HUQXt1MtM73ZqGx5U27a1bGQRfH0SxPBrKP9QnUsGvNc9hCGpmrWS1ERyWtAvr9D7MMQy_EJxRtuG8HoSnh8pE0NKETbPzVCipp2raefqsPMCf_63_Wf075ILQI_Ao_Mw_kelrlc3i6P0DyWNuj0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2431750429</pqid></control><display><type>article</type><title>Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation</title><source>Access via Wiley Online Library</source><creator>Guzman, Kelly M. ; Brink, Lauren E. ; Rodriguez‐Bey, Guillermo ; Bodnar, Richard J. ; Kuang, Lisha ; Xing, Bin ; Sullivan, Mara ; Park, Hyun J. ; Koppes, Erik ; Zhu, Haining ; Padiath, Quasar ; Cambi, Franca</creator><creatorcontrib>Guzman, Kelly M. ; Brink, Lauren E. ; Rodriguez‐Bey, Guillermo ; Bodnar, Richard J. ; Kuang, Lisha ; Xing, Bin ; Sullivan, Mara ; Park, Hyun J. ; Koppes, Erik ; Zhu, Haining ; Padiath, Quasar ; Cambi, Franca</creatorcontrib><description>Fused in sarcoma (FUS) is a predominantly nuclear multifunctional RNA/DNA‐binding protein that regulates multiple aspects of gene expression. FUS mutations are associated with familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobe degeneration (FTLD) in humans. At the molecular level, the mutated FUS protein is reduced in the nucleus but accumulates in cytoplasmic granules. Oligodendrocytes (OL) carrying clinically relevant FUS mutations contribute to non‐cell autonomous motor neuron disease progression, consistent with an extrinsic mechanism of disease mediated by OL. Knocking out FUS globally or in neurons lead to behavioral abnormalities that are similar to those present in FTLD. In this study, we sought to investigate whether an extrinsic mechanism mediated by loss of FUS function in OL contributes to the behavioral phenotype. We have generated a novel conditional knockout (cKO) in which Fus is selectively depleted in OL (FusOL cKO). The FusOL cKO mice show increased novelty‐induced motor activity and enhanced exploratory behavior, which are reminiscent of some manifestations of FTLD. The phenotypes are associated with greater myelin thickness, higher number of myelinated small diameter axons without an increase in the number of mature OL. The expression of the rate‐limiting enzyme of cholesterol biosynthesis (HMGCR) is increased in white matter tracts of the FusOLcKO and results in higher cholesterol content. In addition, phosphorylation of Akt, an important regulator of myelination is increased in the FusOLcKO. Collectively, this work has uncovered a novel role of oligodendrocytic Fus in regulating myelin deposition through activation of Akt and cholesterol biosynthesis.
Myelin thickness and myelinated small axons are increased in FusOLcKO mice.
Activation of HMGCR expression leads to higher cholesterol in FusOLcKO mice.
Akt is activated in FusOLcKO mice.
FusOLcKO mice exhibit enhanced exploration and motor activity</description><identifier>ISSN: 0894-1491</identifier><identifier>EISSN: 1098-1136</identifier><identifier>DOI: 10.1002/glia.23825</identifier><identifier>PMID: 32187401</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Abnormalities ; Activation ; Akt ; AKT protein ; Amyotrophic lateral sclerosis ; Axons ; Biosynthesis ; Cholesterol ; Degeneration ; Deoxyribonucleic acid ; Depletion ; Deposition ; Diameters ; DNA ; Exploratory behavior ; FTLD ; Fus ; FUS gene ; FUS protein ; Gene expression ; Hyperactivity ; Motor activity ; Motor neuron diseases ; Mutation ; Myelin ; Myelination ; Oligodendrocytes ; Phenotypes ; Phosphorylation ; Proteins ; Ribonucleic acid ; RNA ; Sarcoma ; Substantia alba</subject><ispartof>Glia, 2020-10, Vol.68 (10), p.2040-2056</ispartof><rights>2020 Wiley Periodicals, Inc.</rights><rights>2020 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4485-85edc37bf8e06e88739838085944a159bc305d0369682509219991e9d819c043</citedby><cites>FETCH-LOGICAL-c4485-85edc37bf8e06e88739838085944a159bc305d0369682509219991e9d819c043</cites><orcidid>0000-0002-3094-1501 ; 0000-0001-7066-1013</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fglia.23825$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fglia.23825$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32187401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guzman, Kelly M.</creatorcontrib><creatorcontrib>Brink, Lauren E.</creatorcontrib><creatorcontrib>Rodriguez‐Bey, Guillermo</creatorcontrib><creatorcontrib>Bodnar, Richard J.</creatorcontrib><creatorcontrib>Kuang, Lisha</creatorcontrib><creatorcontrib>Xing, Bin</creatorcontrib><creatorcontrib>Sullivan, Mara</creatorcontrib><creatorcontrib>Park, Hyun J.</creatorcontrib><creatorcontrib>Koppes, Erik</creatorcontrib><creatorcontrib>Zhu, Haining</creatorcontrib><creatorcontrib>Padiath, Quasar</creatorcontrib><creatorcontrib>Cambi, Franca</creatorcontrib><title>Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation</title><title>Glia</title><addtitle>Glia</addtitle><description>Fused in sarcoma (FUS) is a predominantly nuclear multifunctional RNA/DNA‐binding protein that regulates multiple aspects of gene expression. FUS mutations are associated with familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobe degeneration (FTLD) in humans. At the molecular level, the mutated FUS protein is reduced in the nucleus but accumulates in cytoplasmic granules. Oligodendrocytes (OL) carrying clinically relevant FUS mutations contribute to non‐cell autonomous motor neuron disease progression, consistent with an extrinsic mechanism of disease mediated by OL. Knocking out FUS globally or in neurons lead to behavioral abnormalities that are similar to those present in FTLD. In this study, we sought to investigate whether an extrinsic mechanism mediated by loss of FUS function in OL contributes to the behavioral phenotype. We have generated a novel conditional knockout (cKO) in which Fus is selectively depleted in OL (FusOL cKO). The FusOL cKO mice show increased novelty‐induced motor activity and enhanced exploratory behavior, which are reminiscent of some manifestations of FTLD. The phenotypes are associated with greater myelin thickness, higher number of myelinated small diameter axons without an increase in the number of mature OL. The expression of the rate‐limiting enzyme of cholesterol biosynthesis (HMGCR) is increased in white matter tracts of the FusOLcKO and results in higher cholesterol content. In addition, phosphorylation of Akt, an important regulator of myelination is increased in the FusOLcKO. Collectively, this work has uncovered a novel role of oligodendrocytic Fus in regulating myelin deposition through activation of Akt and cholesterol biosynthesis.
Myelin thickness and myelinated small axons are increased in FusOLcKO mice.
Activation of HMGCR expression leads to higher cholesterol in FusOLcKO mice.
Akt is activated in FusOLcKO mice.
FusOLcKO mice exhibit enhanced exploration and motor activity</description><subject>Abnormalities</subject><subject>Activation</subject><subject>Akt</subject><subject>AKT protein</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Axons</subject><subject>Biosynthesis</subject><subject>Cholesterol</subject><subject>Degeneration</subject><subject>Deoxyribonucleic acid</subject><subject>Depletion</subject><subject>Deposition</subject><subject>Diameters</subject><subject>DNA</subject><subject>Exploratory behavior</subject><subject>FTLD</subject><subject>Fus</subject><subject>FUS gene</subject><subject>FUS protein</subject><subject>Gene expression</subject><subject>Hyperactivity</subject><subject>Motor activity</subject><subject>Motor neuron diseases</subject><subject>Mutation</subject><subject>Myelin</subject><subject>Myelination</subject><subject>Oligodendrocytes</subject><subject>Phenotypes</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Sarcoma</subject><subject>Substantia alba</subject><issn>0894-1491</issn><issn>1098-1136</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kcFuGyEQQFHVqnHSXvoBFVIvVaRNYGG9cKlkWU0ayVIuuSMMY5uUXVxgE-2_9GPL2mnU5NATg-bNY5hB6BMlF5SQ-nLrnb6omaibN2hGiRQVpWz-Fs2IkLyiXNITdJrSPSG0XNr36ITVVLSc0Bn6vQy9ddmFXntsYe9hinHY4KshYVci77bBQm9jMGOGhD1om3AOuAs5RLwb9xC1ye7B5RHr3pYiE0EnsLgbwRdF0YZ0eAPrlIJxOpfko8s7vPiZDzVmFzykDDF4fJDpCf-A3m20T_Dx6TxDd1ff75Y_qtXt9c1ysaoM56KpRAPWsHa9EUDmIETLpGCCiEZyrmkj14aRxhI2l_MyIyJrKqWkIK2g0hDOztC3o3Y_rLuigj5H7dU-uk7HUQXt1MtM73ZqGx5U27a1bGQRfH0SxPBrKP9QnUsGvNc9hCGpmrWS1ERyWtAvr9D7MMQy_EJxRtuG8HoSnh8pE0NKETbPzVCipp2raefqsPMCf_63_Wf075ILQI_Ao_Mw_kelrlc3i6P0DyWNuj0</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Guzman, Kelly M.</creator><creator>Brink, Lauren E.</creator><creator>Rodriguez‐Bey, Guillermo</creator><creator>Bodnar, Richard J.</creator><creator>Kuang, Lisha</creator><creator>Xing, Bin</creator><creator>Sullivan, Mara</creator><creator>Park, Hyun J.</creator><creator>Koppes, Erik</creator><creator>Zhu, Haining</creator><creator>Padiath, Quasar</creator><creator>Cambi, Franca</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3094-1501</orcidid><orcidid>https://orcid.org/0000-0001-7066-1013</orcidid></search><sort><creationdate>202010</creationdate><title>Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation</title><author>Guzman, Kelly M. ; Brink, Lauren E. ; Rodriguez‐Bey, Guillermo ; Bodnar, Richard J. ; Kuang, Lisha ; Xing, Bin ; Sullivan, Mara ; Park, Hyun J. ; Koppes, Erik ; Zhu, Haining ; Padiath, Quasar ; Cambi, Franca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4485-85edc37bf8e06e88739838085944a159bc305d0369682509219991e9d819c043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abnormalities</topic><topic>Activation</topic><topic>Akt</topic><topic>AKT protein</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Axons</topic><topic>Biosynthesis</topic><topic>Cholesterol</topic><topic>Degeneration</topic><topic>Deoxyribonucleic acid</topic><topic>Depletion</topic><topic>Deposition</topic><topic>Diameters</topic><topic>DNA</topic><topic>Exploratory behavior</topic><topic>FTLD</topic><topic>Fus</topic><topic>FUS gene</topic><topic>FUS protein</topic><topic>Gene expression</topic><topic>Hyperactivity</topic><topic>Motor activity</topic><topic>Motor neuron diseases</topic><topic>Mutation</topic><topic>Myelin</topic><topic>Myelination</topic><topic>Oligodendrocytes</topic><topic>Phenotypes</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Sarcoma</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guzman, Kelly M.</creatorcontrib><creatorcontrib>Brink, Lauren E.</creatorcontrib><creatorcontrib>Rodriguez‐Bey, Guillermo</creatorcontrib><creatorcontrib>Bodnar, Richard J.</creatorcontrib><creatorcontrib>Kuang, Lisha</creatorcontrib><creatorcontrib>Xing, Bin</creatorcontrib><creatorcontrib>Sullivan, Mara</creatorcontrib><creatorcontrib>Park, Hyun J.</creatorcontrib><creatorcontrib>Koppes, Erik</creatorcontrib><creatorcontrib>Zhu, Haining</creatorcontrib><creatorcontrib>Padiath, Quasar</creatorcontrib><creatorcontrib>Cambi, Franca</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Glia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guzman, Kelly M.</au><au>Brink, Lauren E.</au><au>Rodriguez‐Bey, Guillermo</au><au>Bodnar, Richard J.</au><au>Kuang, Lisha</au><au>Xing, Bin</au><au>Sullivan, Mara</au><au>Park, Hyun J.</au><au>Koppes, Erik</au><au>Zhu, Haining</au><au>Padiath, Quasar</au><au>Cambi, Franca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation</atitle><jtitle>Glia</jtitle><addtitle>Glia</addtitle><date>2020-10</date><risdate>2020</risdate><volume>68</volume><issue>10</issue><spage>2040</spage><epage>2056</epage><pages>2040-2056</pages><issn>0894-1491</issn><eissn>1098-1136</eissn><abstract>Fused in sarcoma (FUS) is a predominantly nuclear multifunctional RNA/DNA‐binding protein that regulates multiple aspects of gene expression. FUS mutations are associated with familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobe degeneration (FTLD) in humans. At the molecular level, the mutated FUS protein is reduced in the nucleus but accumulates in cytoplasmic granules. Oligodendrocytes (OL) carrying clinically relevant FUS mutations contribute to non‐cell autonomous motor neuron disease progression, consistent with an extrinsic mechanism of disease mediated by OL. Knocking out FUS globally or in neurons lead to behavioral abnormalities that are similar to those present in FTLD. In this study, we sought to investigate whether an extrinsic mechanism mediated by loss of FUS function in OL contributes to the behavioral phenotype. We have generated a novel conditional knockout (cKO) in which Fus is selectively depleted in OL (FusOL cKO). The FusOL cKO mice show increased novelty‐induced motor activity and enhanced exploratory behavior, which are reminiscent of some manifestations of FTLD. The phenotypes are associated with greater myelin thickness, higher number of myelinated small diameter axons without an increase in the number of mature OL. The expression of the rate‐limiting enzyme of cholesterol biosynthesis (HMGCR) is increased in white matter tracts of the FusOLcKO and results in higher cholesterol content. In addition, phosphorylation of Akt, an important regulator of myelination is increased in the FusOLcKO. Collectively, this work has uncovered a novel role of oligodendrocytic Fus in regulating myelin deposition through activation of Akt and cholesterol biosynthesis.
Myelin thickness and myelinated small axons are increased in FusOLcKO mice.
Activation of HMGCR expression leads to higher cholesterol in FusOLcKO mice.
Akt is activated in FusOLcKO mice.
FusOLcKO mice exhibit enhanced exploration and motor activity</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>32187401</pmid><doi>10.1002/glia.23825</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-3094-1501</orcidid><orcidid>https://orcid.org/0000-0001-7066-1013</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0894-1491 |
ispartof | Glia, 2020-10, Vol.68 (10), p.2040-2056 |
issn | 0894-1491 1098-1136 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7772959 |
source | Access via Wiley Online Library |
subjects | Abnormalities Activation Akt AKT protein Amyotrophic lateral sclerosis Axons Biosynthesis Cholesterol Degeneration Deoxyribonucleic acid Depletion Deposition Diameters DNA Exploratory behavior FTLD Fus FUS gene FUS protein Gene expression Hyperactivity Motor activity Motor neuron diseases Mutation Myelin Myelination Oligodendrocytes Phenotypes Phosphorylation Proteins Ribonucleic acid RNA Sarcoma Substantia alba |
title | Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T07%3A00%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conditional%20depletion%20of%20Fus%20in%20oligodendrocytes%20leads%20to%20motor%20hyperactivity%20and%20increased%20myelin%20deposition%20associated%20with%20Akt%20and%20cholesterol%20activation&rft.jtitle=Glia&rft.au=Guzman,%20Kelly%20M.&rft.date=2020-10&rft.volume=68&rft.issue=10&rft.spage=2040&rft.epage=2056&rft.pages=2040-2056&rft.issn=0894-1491&rft.eissn=1098-1136&rft_id=info:doi/10.1002/glia.23825&rft_dat=%3Cproquest_pubme%3E2379020941%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2431750429&rft_id=info:pmid/32187401&rfr_iscdi=true |